Insulin premix
This page covers all Insulin premix drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Insulin receptor.
Targets
Marketed (1)
- Insulin Lispro Premix · Eli Lilly and Company · Diabetes
Insulin lispro premix is a fixed combination of rapid-acting insulin lispro and intermediate-acting insulin isophane that mimics physiologic insulin secretion by providing both mealtime and basal glucose control.
Patent intelligence
- insulin premix patent landscape — aggregated cliff calendar, attackable patents, originator estates